Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 1/20 | 0.51 |
| ▸ | GRM5 | P41594 | 14/20 | 0.43 |
| ▸ | DHFR | P00374 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22066482 | 0.79 | COMT (0.47) | HTR1AHTR7CYP2A6 | |
| SCHEMBL19270160 | 0.73 | HTR1A (0.48) | HTR1AHTR7GRM5DHFRBACE1 | |
| SCHEMBL502867 | 0.73 | KDM4E (0.62) | HTR1AHTR7GRM5CYP2A6 | |
| SCHEMBL29679578 | 0.73 | KDM4E (0.62) | HTR1AHTR7GRM5CYP2A6 | |
| SCHEMBL19270164 | 0.72 | HTR1A (0.50) | HTR1AHTR7GRM5DHFR | |
| SCHEMBL30533680 | 0.71 | KDM4E (0.59) | HTR1AHTR7GRM5CYP2A6 | |
| Hydrochloric Acid SCHEMBL6007318 | 0.71 | KDM4E (0.59) | HTR1AHTR7GRM5CYP2A6 | |
| SCHEMBL21506994 | 0.71 | KDM4E (0.59) | HTR1AHTR7GRM5CYP2A6 | |
| SCHEMBL21692301 | 0.71 | HTR1A (0.55) | HTR1AHTR7GRM5DHFRCYP2A6 | |
| SCHEMBL13537051 | 0.71 | HTR1A (0.76) | HTR1AHTR7GRM5DHFRUSP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | RB1, ARL1, CDKL1 | HTR1A 2066/4885HTR7 3047/4885GRM5 2656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.